An in vivo platform for assessment the delivery therapies via an implantable, replenishable, delivery device, for the treatment of ovarian cancer

被引：0
|
作者：
Sheedy, Aoibhin [1 ,2 ,3 ,4 ]
Shetty, Mihir [1 ,2 ]
Weis, Anna [1 ,2 ]
Benzdick, Laura [1 ,2 ]
Ni, Zhenya [1 ,2 ]
Miller, Jeff [1 ,2 ]
Geller, Melissa [1 ,2 ]
Dolan, Eimear [3 ,4 ]
Felices, Martin [1 ,2 ]
机构：
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Med, Minneapolis, MN USA
[3] Univ Galway, Biomed Engn, Galway, Ireland
[4] Univ Galway, CUram Ctr Res Med Devices, Galway, Ireland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV323/#395
引用
收藏
页码：A248 / A249
页数：2
相关论文
共 50 条
  • [21] ASSESSMENT OF HEAD AND NECK IMMOBILIZATION DEVICE FOR ACCURATE RAPIDARC® TREATMENT DELIVERY
    Al Ahmed, B.
    Khawandanah, E.
    Al Safadi, N.
    Al-Ghamdi, S.
    Saoudi, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S73 - S73
  • [22] A novel ex vivo platform for personalized treatment of metastatic ovarian cancer
    Valdivia, Alain
    Adefulaju, Adebimpe
    Thang, Morrent
    Cuaboy, Luz Andrea
    John, Catherine
    Mann, Breanna
    Satterlee, Andrew
    Bae-Jump, Victoria
    Hingtgen, Shawn
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S211 - S211
  • [23] In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy
    Wauthoz, Nathalie
    Deleuze, Philippe
    Hecq, Julien
    Roland, Isabelle
    Saussez, Sven
    Adanja, Ivan
    Debeir, Olivier
    Decaestecker, Christine
    Mathieu, Veronique
    Kiss, Robert
    Amighi, Karim
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 39 (05) : 402 - 411
  • [24] Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer
    Zahedi, Payam
    De Souza, Raquel
    Huynh, Loan
    Piquette-Miller, Micheline
    Allen, Christine
    MOLECULAR PHARMACEUTICS, 2011, 8 (01) : 260 - 269
  • [25] Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian Cancer
    Winner, Kimberly R. Kanigel
    Steinkamp, Mara P.
    Lee, Rebecca J.
    Swat, Maciej
    Muller, Carolyn Y.
    Moses, Melanie E.
    Jiang, Yi
    Wilson, Bridget S.
    CANCER RESEARCH, 2016, 76 (06) : 1320 - 1334
  • [26] Intraperitoneal Drug Delivery to Improve Efficacy of Targeted Therapies in Mouse Models of Epithelial Ovarian Cancer
    Pathak, Harsh B.
    JOURNAL OF WOMENS HEALTH, 2013, 22 (10) : 896 - 896
  • [27] Trends in Nanomaterials and Processing for Drug Delivery of Polyphenols in the Treatment of Cancer and Other Therapies
    Ciurana, Joaquim
    Rodriguez, Ciro A.
    CURRENT DRUG TARGETS, 2017, 18 (02) : 135 - 146
  • [28] Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
    Marchetti, Claudia
    Palaia, Innocenza
    Giorgini, Margherita
    De Medici, Caterina
    Iadarola, Roberta
    Vertechy, Laura
    Domenici, Lavinia
    Di Donato, Violante
    Tomao, Federica
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    ONCOTARGETS AND THERAPY, 2014, 7 : 1223 - 1236
  • [29] Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly
    Hu, Qinglian
    Li, Wen
    Hu, Xiurong
    Hu, Qida
    Shen, Jie
    Jin, Xue
    Zhou, Jun
    Tang, Guping
    Chu, Paul K.
    BIOMATERIALS, 2012, 33 (27) : 6580 - 6591
  • [30] Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment
    Zhang, Xiaoyang
    Liu, Yarong
    Kim, Yu Jeong
    Mac, John
    Zhuang, Rachel
    Wang, Pin
    RSC ADVANCES, 2017, 7 (32): : 19685 - 19693
12345